// App-Quantinova.ai

: Recruitment, randomization and retention: UK experience of the ‘3 RS’ in osteoarthritis drug trials targeting pain

Researchers

Presenter

  • S. Masters

Principal Investigators

  • P. Lovegrove

  • C. Pereira

  • M. Goff

  • G. Lang

  • T.L. Vincent

  • K. Barker

  • N.K. Arden

  • A. Taylor

  • N. Bottomley

  • W. Jackson

  • A. Price

  • F.E. Watt

Medical Centers

  • University of Oxford, Oxford, United Kingdom

  • Oxford Univ. Hosp. NHS Fndn. Trust, Oxford, United Kingdom

Locations

  • United Kingdom

Companies

  • N/A

Study Components

Therapeutic Area

  • Musculoskeletal

Disease

  • Osteoarthritis

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Randomized

  • Placebo Control

  • Controlled

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved